NASDAQ:NVOS Novo Integrated Sciences (NVOS) Stock Forecast, Price & News $0.13 0.00 (-1.79%) (As of 05:04 PM ET) Add Compare Share Share Today's Range$0.13▼$0.1350-Day Range$0.11▼$0.2052-Week Range$0.10▼$2.14Volume1.83 million shsAverage Volume21.12 million shsMarket Capitalization$18.31 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Novo Integrated Sciences (NASDAQ:NVOS) StockNovo Integrated Sciences, Inc. engages in the provision of medical services. The firm offers specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology, and dental services. Its multi-disciplinary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation, and prevention through its clinics, affiliate clinics, retirement homes, and long-term facilities. The firm operates through the following business segments: healthcare services, and product manufacturing and development. The company was founded by Michael H. Rouse on November 27, 2000 and is headquartered in Bellevue, WA.Read More Receive NVOS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Novo Integrated Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address NVOS Stock News HeadlinesMay 26, 2023 | finance.yahoo.comNovo Integrated Sciences Reports Fiscal Year 2023 Second Quarter Financial ResultsMay 26, 2023 | finance.yahoo.comNovo Integrated Sciences First Quarter 2023 Earnings: US$0.12 loss per share (vs US$0.067 loss in 1Q 2022)June 5, 2023 | Edge On The Street (Ad)Investor Alert: EV Initiatives Create Unsustainable Demand For LithiumThe soaring demand for lithium is driven by worldwide demand for electric vehicles (EVs). Lithium is ideal for electric cars. It's lightweight, stores lots of energy and is rechargeable. Sales of EVs are expected to increase 10-fold by 2030 and estimates are that 1 in 2 cars sold will be electric by 2040.May 24, 2023 | seekingalpha.comNovo Integrated Sciences GAAP EPS of -$0.12, revenue of $3.42MMay 24, 2023 | finance.yahoo.comNovo Integrated Sciences Reports Fiscal Year 2023 First Quarter Financial ResultsApril 27, 2023 | finance.yahoo.comNovo Integrated Sciences Signs Agreements for an Unsecured, Non-dilutive Debt Instrument with a Principal Sum of $70,000,000April 3, 2023 | finance.yahoo.comNovo Integrated Sciences Reports Fiscal Full Year 2022 Financial ResultsMarch 2, 2023 | msn.comA Look Into Novo Integrated Sciences' DebtJune 5, 2023 | Edge On The Street (Ad)Investor Alert: EV Initiatives Create Unsustainable Demand For LithiumThe soaring demand for lithium is driven by worldwide demand for electric vehicles (EVs). Lithium is ideal for electric cars. It's lightweight, stores lots of energy and is rechargeable. Sales of EVs are expected to increase 10-fold by 2030 and estimates are that 1 in 2 cars sold will be electric by 2040.February 23, 2023 | seekingalpha.comNVOS Novo Integrated Sciences, Inc.January 17, 2023 | finance.yahoo.comNovo Integrated Sciences Provides Update on Certain Current Actions and EventsDecember 21, 2022 | finance.yahoo.comNovo Integrated Sciences Announces Receipt of Notice from NasdaqNovember 30, 2022 | finance.yahoo.comNovo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Company, Sarfez Pharmaceuticals, Inc.November 8, 2022 | finance.yahoo.comNovo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Smart Healthcare Solution Provider, TiaTech USA Inc.October 25, 2022 | finance.yahoo.comNovo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Tranquility Lifestyle SolutionsOctober 14, 2022 | msn.comWall Street Set to Open Higher as Earnings Season Accelerates, Ahead of Consumer Sentiment SurveyOctober 14, 2022 | benzinga.comWhy Novo Integrated Sciences Stock Is Trading Lower By Over 50%October 13, 2022 | finance.yahoo.comNovo Integrated Sciences, Inc. Announces Pricing of $2.0 Million Public OfferingOctober 13, 2022 | benzinga.com1NVOS : Novo Integrated Sciences' Subsidiary, Clinical Consultants Int'l,...October 12, 2022 | finance.yahoo.comNovo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Services Agreement with Information Technology Company, SofthreadAugust 29, 2022 | finance.yahoo.comNovo Integrated Sciences, Inc. (NVOS)July 14, 2022 | finance.yahoo.comNovo Integrated Sciences Reports Record Revenue of $13.8 million in Fiscal 2022 Third QuarterJune 23, 2022 | finance.yahoo.comNovo Integrated Sciences’ Chairman and CEO to Present at the AAPI CEO Forum on the Future of Healthcare: Technology, Transformation and BeyondJune 23, 2022 | benzinga.comNovotech Receives CRO Leadership Award for Exceeding Customer ExpectationsApril 26, 2022 | tmcnet.comNovo Integrated Sciences' Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTPApril 26, 2022 | finance.yahoo.comNovo Integrated Sciences’ Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTPApril 13, 2022 | finance.yahoo.comNovo Integrated Sciences Reports Fiscal 2022 Second Quarter Financial ResultsSee More Headlines NVOS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NVOS Company Calendar Today6/05/2023Next Earnings (Estimated)7/13/2023Fiscal Year End8/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Engines & turbines Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NVOS CUSIPN/A CIK1138978 Webnovointegrated.com Phone(206) 617-9797FaxN/AEmployees91Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-32,850,000.00 Net MarginsN/A Pretax Margin-299.28% Return on Equity-99.64% Return on Assets-60.84% Debt Debt-to-Equity RatioN/A Current Ratio0.66 Quick Ratio0.51 Sales & Book Value Annual Sales$11.74 million Price / Sales1.59 Cash FlowN/A Price / Cash FlowN/A Book Value$0.71 per share Price / Book0.18Miscellaneous Outstanding Shares144,860,000Free Float87,784,000Market Cap$18.64 million OptionableNot Optionable Beta-0.55 Key ExecutivesRobert MattacchioneChairman & Chief Executive OfficerChristopher DavidPresident, Chief Operating Officer & DirectorJames ZsebokChief Financial & Accounting OfficerJoseph M. ChalilChief Medical OfficerIndrajit SinhaChief Science OfficerKey CompetitorsBionomicsNASDAQ:BNOXNightHawk BiosciencesNYSE:NHWKEkso BionicsNASDAQ:EKSOHumanigenNASDAQ:HGENOncternal TherapeuticsNASDAQ:ONCTView All Competitors NVOS Stock - Frequently Asked Questions How have NVOS shares performed in 2023? Novo Integrated Sciences' stock was trading at $0.2011 at the beginning of the year. Since then, NVOS shares have decreased by 36.0% and is now trading at $0.1287. View the best growth stocks for 2023 here. When is Novo Integrated Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, July 13th 2023. View our NVOS earnings forecast. What is Novo Integrated Sciences' stock symbol? Novo Integrated Sciences trades on the NASDAQ under the ticker symbol "NVOS." How do I buy shares of Novo Integrated Sciences? Shares of NVOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Novo Integrated Sciences' stock price today? One share of NVOS stock can currently be purchased for approximately $0.13. How much money does Novo Integrated Sciences make? Novo Integrated Sciences (NASDAQ:NVOS) has a market capitalization of $18.64 million and generates $11.74 million in revenue each year. The company earns $-32,850,000.00 in net income (profit) each year or ($1.07) on an earnings per share basis. How can I contact Novo Integrated Sciences? Novo Integrated Sciences' mailing address is 11120 NE 2ND STREET SUITE 100, BELLEVUE WA, 98004. The official website for the company is novointegrated.com. The company can be reached via phone at (206) 617-9797 or via email at info@novointegrated.com. This page (NASDAQ:NVOS) was last updated on 6/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Integrated Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.